[News Brief] Hyperfine Receives Indian Regulatory Approval for Swoop MRI System
Hyperfine, Inc. has secured regulatory clearance from India’s Central Drugs Standard Control Organisation (CDSCO) for its “Swoop” portable brain MRI…
Hyperfine, Inc. has secured regulatory clearance from India’s Central Drugs Standard Control Organisation (CDSCO) for its “Swoop” portable brain MRI…
Curie Oncology, a private oncology network in Southeast Asia, has partnered with health‑tech firm Oncoshot to deploy AI‑powered clinical research…
SL Aesthetic Group has marked 22 years of operation by expanding its medical services and physical footprint across Singapore and…
Fullerton Health has completed the acquisition of The ENT Clinic, a prominent Singapore-based otolaryngology practice, to expand its specialist care…
Sanofi has announced that the US Food and Drug Administration (FDA) has accepted for priority review the supplemental biologics licence…
Takeda has published results from its Phase 3 clinical trials for Zasocitinib, an oral treatment for moderate-to-severe plaque psoriasis. This…
Lunit has announced a collaboration with Daiichi Sankyo to advance research in AI‑driven biomarker discovery and translational oncology. This summary…
Cinclus Pharma Holding AB’s drug linaprazan glurate has been included in China’s 2025 National Reimbursement Drug List (NRDL) ahead of…
A.P. Moller – Maersk has opened its first own‑licensed bonded warehouse in Northern Vietnam, located at SLP Park, Nam Dinh…
ChemLex, an AI-for-science startup, has raised USD 45 million in seed funding to launch a self-driving laboratory for drug discovery…